These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4090619)

  • 21. [Myocardial oxygen consumption and relationship to cardiovascular effects of clinical inodilators].
    Honerjäger P; Mitrovic V; Schlepper M
    Med Klin (Munich); 1994 Feb; 89(2):89-94. PubMed ID: 8164602
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of irreversible heart decompensation and cardiogenic shock with glucagon].
    Bruni B
    Minerva Cardioangiol; 1972; 20(7):419-27. PubMed ID: 5050748
    [No Abstract]   [Full Text] [Related]  

  • 24. [Stimulating and hypobiotic therapy in cardiogenic shock].
    Bobrov VA; Shved NI; Sherman DM
    Lik Sprava; 1994; (5-6):7-12. PubMed ID: 7831916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of cardiogenic shock: focus on tissue perfusion.
    den Uil CA; Lagrand WK; Valk SD; Spronk PE; Simoons ML
    Curr Probl Cardiol; 2009 Aug; 34(8):330-49. PubMed ID: 19591748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular effects of glucagon].
    Gavrilescu S; Streian C
    Med Interna (Bucur); 1972 Apr; 24(4):441-50. PubMed ID: 5027789
    [No Abstract]   [Full Text] [Related]  

  • 27. [Catecholamines in internal medicine emergencies].
    Brandt D; Pristautz H; Klein W
    Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and future perspectives in cardiogenic shock, reperfusion strategies and hemodynamic inotropic support for acute heart failure.
    Beyar R
    Acute Card Care; 2010 Mar; 12(1):1-2. PubMed ID: 20201655
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute heart failure in myocardial infarction: principles of treatment.
    Perret C
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S26-9. PubMed ID: 2403511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 31. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of nonseptic cardiogenic circulatory failure].
    Griebenow R
    Klin Anasthesiol Intensivther; 1995; 47():122-8. PubMed ID: 7715169
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiogenic shock in acute myocardial infarction].
    Martínez A; Corbalán R; González R; Asenjo R; Illanes G; Rodríguez JA
    Rev Med Chil; 1986 Oct; 114(10):947-53. PubMed ID: 2883711
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathomechanisms of heart failure].
    Urbaszek W
    Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608
    [No Abstract]   [Full Text] [Related]  

  • 35. Milrinone: a positive inotropic vasodilator.
    Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
    Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
    [No Abstract]   [Full Text] [Related]  

  • 36. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
    J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
    [No Abstract]   [Full Text] [Related]  

  • 37. A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure.
    Nandkeolyar S; Ryu R; Mohammad A; Cordero-Caban K; Abramov D; Tran H; Hauschild C; Stoletniy L; Hilliard A; Sakr A
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):336-345. PubMed ID: 34117179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heart insufficiency: current aspects of physiopathology and therapy].
    Bolte HD
    Med Klin; 1981 Nov; 76(24):664-71. PubMed ID: 7311926
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug regimens for congestive heart failure.
    Unverferth DV; Magorien RD; Leier CV
    Geriatrics; 1980 Jul; 35(7):26-33. PubMed ID: 7380254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.